These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23196799)
1. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor. Yamamoto H; Kohashi K; Fujita A; Oda Y Mod Pathol; 2013 Apr; 26(4):563-71. PubMed ID: 23196799 [TBL] [Abstract][Full Text] [Related]
2. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors. Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888 [TBL] [Abstract][Full Text] [Related]
3. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray. Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971 [TBL] [Abstract][Full Text] [Related]
5. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor. Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394 [TBL] [Abstract][Full Text] [Related]
6. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors. Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687 [TBL] [Abstract][Full Text] [Related]
7. The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors. Gyvyte U; Lukosevicius R; Inciuraite R; Streleckiene G; Gudoityte G; Bekampyte J; Valentini S; Salteniene V; Ruzgys P; Satkauskas S; Zviniene K; Kupcinskas J; Skieceviciene J Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708220 [TBL] [Abstract][Full Text] [Related]
8. [Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors]. Shi Y; Wang CZ; Hou YY; He DM; Xu C; Liu YL; Hu Q; Akesu S; Zeng HY; Shen KT; Tan YS; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):20-5. PubMed ID: 23611268 [TBL] [Abstract][Full Text] [Related]
9. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259 [TBL] [Abstract][Full Text] [Related]
10. The rs17084733 variant in the Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504 [TBL] [Abstract][Full Text] [Related]
11. Expression profiles of stemness genes in gastrointestinal stromal tumor. Bai C; Liu X; Xu J; Qiu C; Wang R; Zheng J Hum Pathol; 2018 Jun; 76():76-84. PubMed ID: 29486292 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and Prognostic Significance of Expression of B-Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (BMI-1) Gene and Protein in Gastrointestinal Stromal Tumors. Zhu K; Li K; Yuan DW; Xu G; Kang L; Dang CX; Zhang Y Med Sci Monit; 2018 Sep; 24():6414-6421. PubMed ID: 30209248 [TBL] [Abstract][Full Text] [Related]
13. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location. Wei YC; Li CF; Yu SC; Chou FF; Fang FM; Eng HL; Uen YH; Tian YF; Wu JM; Li SH; Huang WW; Li WM; Huang HY Mod Pathol; 2009 Oct; 22(10):1351-60. PubMed ID: 19648886 [TBL] [Abstract][Full Text] [Related]
14. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach. Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007 [TBL] [Abstract][Full Text] [Related]
15. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092 [TBL] [Abstract][Full Text] [Related]
16. Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor. Kou Y; Yang R; Wang Q J Biosci; 2018 Dec; 43(5):1015-1023. PubMed ID: 30541960 [TBL] [Abstract][Full Text] [Related]
17. Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors. Pantaleo MA; Ravegnini G; Astolfi A; Simeon V; Nannini M; Saponara M; Urbini M; Gatto L; Indio V; Sammarini G; Santini D; Ferracin M; Negrini M; Hrelia P; Biasco G; Angelini S Epigenomics; 2016 Oct; 8(10):1347-1366. PubMed ID: 27625077 [TBL] [Abstract][Full Text] [Related]
18. miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2. Chen Y; Qin C; Cui X; Geng W; Xian G; Wang Z J Cell Physiol; 2020 Jul; 235(7-8):5711-5721. PubMed ID: 31975384 [TBL] [Abstract][Full Text] [Related]
19. Fascin expression and its potential significance in gastrointestinal stromal tumors. Ozcan A; Karslioğlu Y; Günal A; Cermık AH; Kurt B; Ongürü O Turk J Gastroenterol; 2011 Aug; 22(4):363-8. PubMed ID: 21948565 [TBL] [Abstract][Full Text] [Related]
20. Imatinib Regulates Huang WK; Shi H; Akçakaya P; Zeljic K; Gangaev A; Caramuta S; Yeh CN; Bränström R; Larsson C; Lui WO Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]